Literature DB >> 22761986

Reactivation of tuberculosis in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A report of 3 cases.

Yun Jeung Kim1, Pyung Gohn Goh, Hee Seok Moon, Eaum Seok Lee, Seok Hyun Kim, Byung Seok Lee, Heon Young Lee.   

Abstract

Pulmonary tuberculosis is an opportunistic infection that can be reactivated in immunocompromised conditions, for example, in malignancy or after liver transplantation. Hepatocellular carcinoma (HCC) has a high mortality rate because it is frequently diagnosed at an advanced stage. Although surgical resection is the established curative measure for HCC, it is only feasible for early-stage HCC. Transcatheter arterial chemoembolization (TACE) is the most common treatment modality for patients with unresectable HCC. However, repeated TACE sessions and, occasionally, the tumor itself can further impair the reserve hepatic function and immunity. We report 3 recent cases of HCC with reactivation of pulmonary tuberculosis after TACE.

Entities:  

Keywords:  Hepatocellular carcinoma; Reactivation; Transcatheter arterial chemoembolization; Tuberculosis

Year:  2012        PMID: 22761986      PMCID: PMC3386538          DOI: 10.4329/wjr.v4.i5.236

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  11 in total

1.  API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.

Authors: 
Journal:  J Assoc Physicians India       Date:  2006-03

2.  Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).

Authors:  Renumathy Dhanasekaran; David A Kooby; Charles A Staley; John S Kauh; Vinit Khanna; Hyun S Kim
Journal:  J Surg Oncol       Date:  2010-05-01       Impact factor: 3.454

3.  Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation.

Authors:  Albert C Y Chan; Chung Mau Lo; Kelvin Kwok Chai Ng; See Ching Chan; Sheung Tat Fan
Journal:  Liver Int       Date:  2007-02       Impact factor: 5.828

Review 4.  Updated treatment approach to hepatocellular carcinoma.

Authors:  Josep M Llovet
Journal:  J Gastroenterol       Date:  2005-03       Impact factor: 7.527

5.  Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.

Authors:  Maurizio Biselli; Pietro Andreone; Annagiulia Gramenzi; Franco Trevisani; Carmela Cursaro; Cristina Rossi; Salvatore Ricca Rosellini; Carlo Cammà; Stefania Lorenzini; Giuseppe Francesco Stefanini; Giovanni Gasbarrini; Mauro Bernardi
Journal:  Clin Gastroenterol Hepatol       Date:  2005-09       Impact factor: 11.382

6.  Ruptured hepatocellular carcinoma following chemoembolization: a western experience.

Authors:  Narendra Battula; Parthi Srinivasan; Mansoor Madanur; Srinivas Prabhu Chava; Oliver Priest; Mohamed Rela; Nigel Heaton
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-02

Review 7.  Review article: the management of hepatocellular carcinoma.

Authors:  R Cabrera; D R Nelson
Journal:  Aliment Pharmacol Ther       Date:  2009-11-19       Impact factor: 8.171

Review 8.  Treatment before liver transplantation for HCC.

Authors:  J Belghiti; B I Carr; P D Greig; R Lencioni; R T Poon
Journal:  Ann Surg Oncol       Date:  2008-01-31       Impact factor: 5.344

9.  Tuberculosis in oncology patients.

Authors:  D C Stefan; A L Kruis; H S Schaaf; G Wessels
Journal:  Ann Trop Paediatr       Date:  2008-06

10.  Reactivation of pulmonary tuberculosis in malignancy.

Authors:  Demet Karnak; Oya Kayacan; Sumru Beder
Journal:  Tumori       Date:  2002 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.